Answers are grounded in this paper and cite their sources.
Observational analysis improved treatment outcomes in breast cancer by overcoming multidrug resistance, indicating the potential of novel nanocapsules.
Cancer remains one of the leading causes of mortality worldwide. Among current treatment strategies, chemotherapy continues to play a central role; however, its therapeutic efficacy is markedly compromised by the development of multidrug resistance (MDR) in cancer cells. To address this challenge, a new triblock copolymer, poly(ethylene glycol)-b-poly(lactide)-b-poly(cationic polylactide) (PEG-b-PLA-b-CPLA), was first synthesized and converted into biodegradable charged nanocapsules (BCNCs) without the use of surfactants or additives via our developed nanoemulsion interfacial cross-linking technique. With favorable biodegradability, BCNCs exhibit the ability to coload both hydrophobic drugs and hydrophilic genes. Compared with other drug/gene carriers, they feature controllable charge and surface poly(ethylene glycol) (PEG) density, high colloidal stability, and sequential release of the loaded genes and drugs. When loaded with a hydrophobic anticancer drug, dehydrochlorination doxorubicin (Dox), and a hydrophilic P-glycoprotein (Pgp) silencing gene (Pgp-siRNA), the resulting Pgp-siRNA/Dox-coloaded BCNCs successfully demonstrated the ability to overcome MDR in MCF-7/ADR cells, due to enhanced cellular uptake, Pgp silencing efficiency, and effective endosomal/lysosomal escape of the loaded therapeutics.
No takes yet. Share an insight, caveat, or question.
Cheng-Hsi Chang (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: